bpc 157 alone or with tb500 Revolutionizing Recovery: How Dr. Lundquist is Using BPC-157, TB-500, and Regenerative Therapies to Accelerate Healing Breakthrough Peptide Healing: How BPC-157

(jofem.org) The best-case signal: modest weight loss in a shorter trial A frequently cited 12-week randomized trial result (as summarized in reviews) reported: ~2.6 kg average loss with AOD-9604 1 mg/day vs ~0.8 kg with placebo (PMC) This is the kind of result that can be statistically meaningful, clinically modest, and very sensitive to study design (diet, activity, baseline metabolic status, adherence)

The important caveat is that Retatrutide remains in Phase 3 trials and has not yet received prescription approval in Canada or the US

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

Draw the desired amount of BAC water into an insulin syringe, insert the needle through the vials rubber stopper, and slowly release the water along the inside wall of the vial

People with substantial weight to lose